# Clinical trials recruiting in Costa Rica: 24 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials recruiting or not yet recruiting with a site in Costa Rica, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Costa Rica: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/costa-rica

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| April 20, 2026 | NCT07538960 | Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica. | Sponsor not shown (see the record) | Observational | Not yet recruiting | Lymph Node Cancer, Cutaneous, T-cell Lymphoma | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07538960) |
| April 13, 2026 | NCT07524803 | Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM) | Latin American Consortium for the Lung Cancer Research | Observational | Not yet recruiting | Lung Cancer Screening | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07524803) |
| March 27, 2026 | NCT07497815 | Artificial Intelligence-assisted Diagnosis in Ophthalmology | Sponsor not shown (see the record) | Observational | Not yet recruiting | Macular Degeneration, Diabetic Retinopathy (DR), Glaucoma, Keratoconus, Cataract | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497815) |
| March 5, 2026 | NCT07451626 | Clinical, Epidemiologic, and Therapeutic Characterization of Pediatric Psoriasis in the Costa Rican Social Security System | Sponsor not shown (see the record) | Observational | Not yet recruiting | Pediatric Psoriasis | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07451626) |
| March 4, 2026 | NCT07448428 | Generalized Pustular Psoriasis Registry in Costa Rica | Sponsor not shown (see the record) | Observational | Not yet recruiting | Generalized Pustular Psoriasis, Generalized Pustular Psoriasis (GPP) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448428) |
| March 4, 2026 | NCT07448402 | Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease | Sponsor not shown (see the record) | Observational | Not yet recruiting | Psoriasis, Psoriasis Arthritis, Psoriasis (PsO) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448402) |
| March 4, 2026 | NCT07448389 | Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025) | Sponsor not shown (see the record) | Observational | Not yet recruiting | Leprosy, Hansen's Disease, Leprosy--Patients, Lepromatous Leprosy, Leprosy, Multibacillary, Leprosy Neuropathy | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448389) |
| March 4, 2026 | NCT07448363 | Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica | Sponsor not shown (see the record) | Observational | Not yet recruiting | Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema), Atopic Dermatitis Patients, Atopic Dermatitis /... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448363) |
| March 4, 2026 | NCT07448337 | Psoriasis Comorbidities at Hospital Calderón Guardia | Sponsor not shown (see the record) | Observational | Not yet recruiting | Psoriasis, Psoriasis Arthritis, Psoriasis (PsO), Psoriasis Patients | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448337) |
| August 21, 2025 | NCT07135011 | Adaptive Study to Assess the Safety and Functioning of Motiva Devices on Minimally Invasive Gluteal Augmentation | Sponsor not shown (see the record) | Not applicable | Recruiting | Device Safety | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07135011) |
| May 28, 2025 | NCT06991517 | A Study of Transcatheter Aortic Valve Replacement Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm | World Health Research Inc. | Observational | Recruiting | Aortic Stenosis | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06991517) |
| March 10, 2025 | NCT06868277 | A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell... | AstraZeneca | Phase 3 | Recruiting | Carcinoma, Non-Small Cell Lung | 830 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06868277) |
| April 3, 2024 | NCT06345729 | A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Non-small Cell Lung Cancer | 348 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06345729) |
| March 18, 2024 | NCT06314282 | INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use | AstraZeneca | Observational | Recruiting | Systemic Lupus Erythematosus (SLE) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06314282) |
| March 15, 2024 | NCT06312176 | A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Breast Neoplasms | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06312176) |
| November 24, 2023 | NCT06146231 | Motiva Flora® Aesthetic Breast Recon® Clinical Study | Sponsor not shown (see the record) | Not applicable | Recruiting | Mammaplasty, Breast Cancer, Poland Syndrome | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06146231) |
| November 18, 2023 | NCT06136650 | A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms | 1,314 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06136650) |
| May 17, 2023 | NCT05862285 | A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study | Hoffmann-La Roche | Phase 3 | Recruiting | Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05862285) |
| January 25, 2023 | NCT05696561 | Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma | New World Medical, Inc. | Not applicable | Recruiting | OAG - Open-Angle Glaucoma | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05696561) |
| August 19, 2022 | NCT05508360 | "Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2) | Sponsor not shown (see the record) | Not applicable | Recruiting | Degenerative Disc Disease, Chronic Low-back Pain | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05508360) |
| December 1, 2021 | NCT05139017 | A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large... | Merck Sharp & Dohme LLC | Phase 2/3 | Recruiting | DLBCL, Diffuse Large B-Cell Lymphoma | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05139017) |
| December 2, 2019 | NCT04181970 | Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK | Grupo Espanol de Investigacion en Sarcomas | Observational | Recruiting | Soft-tissue Sarcoma, Gastrointestinal Stromal Tumors, Bone Sarcoma | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04181970) |
| June 8, 2018 | NCT03549754 | iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases | AstraZeneca | Observational | Recruiting | Type 2 Diabetes, Hypertension, Chronic Kidney Disease, Heart Failure | 35,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03549754) |
| April 3, 2018 | NCT03486873 | Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Solid Tumors, Hematologic Malignancies | 3,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03486873) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Hospital Metropolitano - Sede Lindora | Santa Ana | 3 |
| Onco Tech, S.A. | San José | 2 |
| Hospital Metropolitano - Sede Lindora-Metropolitano Research Institute Sede Lindora | Santa Ana | 1 |
| Hospital UNIBE | San José | 1 |
| Hospital San Vicente de Paúl | Heredia | 1 |
| Hospital México | San José | 1 |
| Life Science Center for Innovation Hospital Clinica Biblica | San José | 1 |
| Centro de Investigacion y Manejo del Cancer (CIMCA) | San José | 1 |
| Hospital San Juan de Dios | San José | 1 |
| Clinica CIMCA | San José | 1 |
| ICIMED Instituto de Investigación en Ciencias Médicas | San José | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2/3 | 1 |
| Phase 3 | 6 |
| Not applicable | 4 |
| Observational | 13 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Psoriasis | 4 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 2 |
| Prostatic Neoplasms | 1 |
| Poland Syndrome | 1 |
| Sarcoma | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Bone Neoplasms | 1 |
| Macular Degeneration | 1 |
| Diabetic Retinopathy | 1 |
| Glaucoma | 1 |
| Keratoconus | 1 |
| Cataract | 1 |
| Lymphoma, T-Cell | 1 |
| Lymphoma, T-Cell, Cutaneous | 1 |
| Intervertebral Disc Degeneration | 1 |
| Intervertebral Disc Displacement | 1 |
| Low Back Pain | 1 |
| Lung Neoplasms | 1 |
| Dermatitis, Atopic | 1 |
| Eczema | 1 |
| Hematologic Neoplasms | 1 |
| Glaucoma, Open-Angle | 1 |
| Aortic Valve Stenosis | 1 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 5 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 3 |
| Grupo Espanol de Investigacion en Sarcomas | 1 |
| Latin American Consortium for the Lung Cancer Research | 1 |
| New World Medical, Inc. | 1 |
| World Health Research Inc. | 1 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Merchandising companies in the United States](https://specstream.ai/data/businesses/merchandising-companies/united-states)
- [Irish restaurants in the United States](https://specstream.ai/data/businesses/irish-restaurants/united-states)
- [Graphic design firms in the United States](https://specstream.ai/data/businesses/graphic-design-firms/united-states)
- [Environmental services in the United States](https://specstream.ai/data/businesses/environmental-services/united-states)
- [Coworking spaces in the United States](https://specstream.ai/data/businesses/coworking-spaces/united-states)
- [Business law firms in the United States](https://specstream.ai/data/businesses/business-law-firms/united-states)
